A single molecule today can trigger filings across continents, face scrutiny from multiple regulators, and invite challenges before it ever reaches patients. Drug companies now do business within a context defined by patent cliffs, tighter demands on patentability and inconsistent international regulations on exclusivity.
Different jurisdictions, like India, the USA, and Europe, view the same invention through an entirely different lens and compel companies to think beyond patenting and consider intellectual property as a subset of a broader business strategy.
It is within this layered environment that GNP Legal Consulting has steadily shaped its role. The firm was established in 2016 as a specialized intellectual property practice, to help life sciences companies navigate the challenges arising from fragmented IP and regulatory solutions.
Since inception, the firm operated under the philosophy that there is no way that protection strategies could be separated from the manner in which products are developed, approved, and ultimately commercialized. This thinking eventually formed the core of how the firm operates.
Intellectual Property Across the Product Lifecycle
Priyanka Mehta, Founder at GNP Legal Consulting says, “Instead of viewing patents as single filings, we view intellectual property as something that develops with a product. We counsel clients on end-to-end IP strategy and execution, from patent portfolio development to commercialization of the Product offering global patent landscaping, freedom-to-operate assessments, opposition and revocation proceedings, IP due diligence, and litigation services across the USA, EU, and India.”
Context is what links these services. Every decision is undertaken with knowledge of regulatory timeframes, market entry risk and commercial intent in the long run.
This broader perspective stretches our services into contractual and commercial advisory space. We help clients with legal agreements, licensing arrangements, research collaborations, commercial contracts and strategic partnerships to the exercise of rights once granted.
For clients, this means fewer disconnects between legal protection and business execution. GNP Legal Consulting has over the years developed a reputation of assisting companies to prevent expensive misalignment at an earlier stage rather than solving such issues later.
We counsel clients on end-to-end IP strategy and execution, from patent portfolio development to commercialization of the Product, offering global patent landscaping, freedom-to-operate assessments, patent drafting and prosecution, opposition and revocation proceedings, IP due diligence, and litigation services across USA, EU, and IndiaPriyanka Mehta, Founder
Scientific Insight Guiding Intellectual Property Decisions
Much of this clarity comes from the people behind the work. The firm’s team includes scientists that have transitioned to legal practice, as well as field specialists educated in chemistry, pharmaceuticals and biotechnology. This combination enables the complex inventions to be discussed in their own scientific terms prior to application of legal framework.
This fluency is particularly crucial in fields such as AI-assisted drug discovery where the issue of inventorship, disclosure, and data ownership are still emerging. The professionals in the firm address these problems with technical knowledge and legal discipline instead of following any strict template.
This has assisted in developing confidence among clients who work in fast-moving research environments and need advice that reflects real-world uncertainty.
Technology has a definite role in the functioning of the firm but it is not considered the goal itself. The analysis of large amounts of patent data, prior art identification, and competitive risk identification are conducted with AI-driven tools more effectively. Repetitive processes are enhanced by automation, which enhances consistency and turnaround time.
However, what remains central is judgment. Strategic decisions, portfolio design, and litigation planning continue to depend on experienced professionals who understand the limits of automation. In addition to this, GNP Legal Consulting invests in ongoing internal research, monitoring scientific developments and changes in the global IP law. This continuous learning enables the firm to foresee problems instead of responding to them.
Extending Capability through Strategic Partnerships
Since its early years, the firm’s footprint has expanded in both scale and scope. The team has experience in drafting and prosecuting hundreds of patent applications, obtaining a significant number of patents granted, cross-border disputes, and commercial contract negotiation of various types. Mentoring start-ups and encouraging IPO-related intellectual property certifications have further given it a new dimension in its work.
Strategic partnership with law firms of major international markets enables issues to be addressed across boundaries. Cost control has also been a steady area of interest, especially in complicated international cases where costs can increase rapidly. It is this equilibrium between coverage and effectiveness that has determined the way GNP Legal Consulting is evolving.
The firm’s teams experience spans the full IP lifecycle, with more than 400 patent applications, over 270 granted patents, more than 19 cross-border litigations, and more than 540 commercial contracts, alongside mentoring India’s top 100 start-ups. Notably, US patent litigations have been managed at nearly one-tenth of the average cost reported by AIPLA (American Intellectual Property Law Association).
Guiding Innovation with Strategic IP
Moving forward, the firm’s direction reflects the same principles that guided its early years. The growth in new fields like advanced biotechnology, medical devices and AI based research is accompanied by increased integration of IP, legal, regulatory and business advisory services. Rather than chasing scale alone, GNP Legal Consulting appears intent on staying closely aligned with how innovation actually moves from lab to market. In an industry where accuracy, time, and place are equally important as safety, the development of the firm highlights one simple concept. “The concept of intellectual property is no longer only about securing rights. It is about ensuring that those rights operate, change, and survive,” concludes Priyanka.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")